Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)

NCT06553768 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)

Interventions

DRUG: Maralixibat
OTHER: Placebo

Sponsor

Mirum Pharmaceuticals, Inc.